The Automatic Implantable Cardioverter-Defibrillator: Clinical Experience, Complications, and Follow-up in 25 Patients

Keyphrases

• Clinical Experience 100%
• Ventricular Arrhythmia 100%
• Survival Rate 100%
• Cardioversion 100%
• Automatic Implantable Cardioverter Defibrillator 100%
• Clinical Infections 50%
• High-risk Population 50%
• Electrogram 50%
• Reoperation 50%
• Electrophysiologic 50%
• Ventricular Fibrillation 50%
• Patient Discharge 50%
• Ventricular Tachycardia 50%
• Device Failure 50%
• Energy Requirement 50%
• Antiarrhythmic Drugs 50%
• Drug Trials 50%
• Early Follow-up 50%
• Length of Follow-up 50%
• Syncope 50%
• Cardiac Arrest 50%
• Arrhythmic Death 50%
• Sustained Ventricular Tachycardia 50%
• Defibrillation 50%
• Periprocedural Myocardial Infarction 50%
• Late Follow-up 50%
• Seroma 50%
• In-hospital Complications 50%
• Monomorphic Ventricular Tachycardia 50%
• Life Table Analysis 50%
• Post-hospital 50%
• Device Deactivation 50%
• Unintentional Discharge 50%
• Pleomorphic Ventricular Tachycardia 50%
• Sensing Failure 50%

Medicine and Dentistry

• Implantable Automatic Defibrillator 100%
• Ventricular Tachycardia 100%
• Survival Rate 66%
• Cardioversion 66%
• Heart Ventricle Arrhythmia 33%
• Myocardial Infarction 33%
• High Risk Population 33%
• Faintness 33%
• Ventricular Fibrillation 33%
• Sustained Ventricular Tachycardia 33%
• Infection 33%
• Reoperation 33%
• Drug Screening 33%
• Life Table 33%
• Heart Arrest 33%
• Antiarrhythmic Agent 33%
• Defibrillation 33%
• Electrography 33%
• Seroma 33%
• Device Failure 33%